ArticleClinical and translational medicine2022

Melatonergic signalling instructs transcriptional inhibition of IFNGR2 to lessen interleukin-1β-dependent inflammation.

Yaoyao Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.